BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33516743)

  • 1. Late-Stage Melanoma in New York State: Associations with Socioeconomic Factors and Healthcare Access at the County Level.
    Shah P; Shao Y; Geller AC; Polsky D
    J Invest Dermatol; 2021 Jul; 141(7):1699-1706.e7. PubMed ID: 33516743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of demographics, socioeconomics, and health care access on melanoma outcomes.
    Cortez JL; Vasquez J; Wei ML
    J Am Acad Dermatol; 2021 Jun; 84(6):1677-1683. PubMed ID: 32783908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of primary care provider density on detection and diagnosis of cutaneous melanoma.
    Fleming NH; Grade MM; Bendavid E
    PLoS One; 2018; 13(7):e0200097. PubMed ID: 30005065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of neighborhood risk for late-stage melanoma: addressing disparities through spatial analysis and area-based measures.
    Hu S; Sherman R; Arheart K; Kirsner RS
    J Invest Dermatol; 2014 Apr; 134(4):937-945. PubMed ID: 24335896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continued Increase in Melanoma Incidence across all Socioeconomic Status Groups in California, 1998-2012.
    Clarke CA; McKinley M; Hurley S; Haile RW; Glaser SL; Keegan THM; Swetter SM
    J Invest Dermatol; 2017 Nov; 137(11):2282-2290. PubMed ID: 28736233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant melanoma of the skin in Upstate New York: recent trends and characteristics.
    Polednak AP
    Cancer Detect Prev; 1985; 8(4):485-95. PubMed ID: 4053111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of cutaneous melanoma incidence with area-based socioeconomic indicators-United States, 2004-2006.
    Singh SD; Ajani UA; Johnson CJ; Roland KB; Eide M; Jemal A; Negoita S; Bayakly RA; Ekwueme DU
    J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S58-68. PubMed ID: 22018068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distance to diagnosing provider as a measure of access for patients with melanoma.
    Stitzenberg KB; Thomas NE; Dalton K; Brier SE; Ollila DW; Berwick M; Mattingly D; Millikan RC
    Arch Dermatol; 2007 Aug; 143(8):991-8. PubMed ID: 17709657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study.
    Clegg LX; Reichman ME; Miller BA; Hankey BF; Singh GK; Lin YD; Goodman MT; Lynch CF; Schwartz SM; Chen VW; Bernstein L; Gomez SL; Graff JJ; Lin CC; Johnson NJ; Edwards BK
    Cancer Causes Control; 2009 May; 20(4):417-35. PubMed ID: 19002764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seasonal patterns in the diagnosis of malignant melanoma of skin and eye in upstate New York.
    Polednak AP
    Cancer; 1984 Dec; 54(11):2587-94. PubMed ID: 6498751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using SEER data to quantify effects of low income neighborhoods on cause specific survival of skin melanoma.
    Cheung MR
    Asian Pac J Cancer Prev; 2013; 14(5):3219-21. PubMed ID: 23803107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health Disparities Influence Childhood Melanoma Stage at Diagnosis and Outcome.
    Hamilton EC; Nguyen HT; Chang YC; Eberth JM; Cormier J; Elting LS; Austin MT
    J Pediatr; 2016 Aug; 175():182-7. PubMed ID: 27233520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin Cancer in Hispanics in the United States.
    Perez MI
    J Drugs Dermatol; 2019 Mar; 18(3):s117-120. PubMed ID: 30909356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial disparities and insurance status: An epidemiological analysis of Ohio melanoma patients.
    Kooistra L; Chiang K; Dawes S; Gittleman H; Barnholtz-Sloan J; Bordeaux J
    J Am Acad Dermatol; 2018 May; 78(5):998-1000. PubMed ID: 29138060
    [No Abstract]   [Full Text] [Related]  

  • 15. Socioeconomic Status and Melanoma in Canada: A Systematic Review.
    Li HO; Bailey AJ; Grose E; McDonald JT; Quimby A; Johnson-Obaseki S; Nessim C
    J Cutan Med Surg; 2021; 25(1):87-94. PubMed ID: 32955341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease mapping of early- and late-stage cancer to monitor inequalities in early detection: a study of cutaneous malignant melanoma.
    Strömberg U; Parkes BL; Holmén A; Peterson S; Holmberg E; Baigi A; Piel FB
    Eur J Epidemiol; 2020 Jun; 35(6):537-547. PubMed ID: 32350689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demographic predictors of melanoma stage at diagnosis.
    Van Durme DJ; Ferrante JM; Pal N; Wathington D; Roetzheim RG; Gonzalez EC
    Arch Fam Med; 2000 Jul; 9(7):606-11. PubMed ID: 10910307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma incidence, recurrence, and mortality in an integrated healthcare system: A retrospective cohort study.
    Feigelson HS; Powers JD; Kumar M; Carroll NM; Pathy A; Ritzwoller DP
    Cancer Med; 2019 Aug; 8(9):4508-4516. PubMed ID: 31215776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late-Stage Melanoma: Be Sure to Screen Uninsured, Unmarried Men.
    Valentin VL; Sanderson W; Westneat S; Durbin E
    South Med J; 2018 Nov; 111(11):649-653. PubMed ID: 30391998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining the pathways linking lower socioeconomic status and advanced melanoma.
    Pollitt RA; Swetter SM; Johnson TM; Patil P; Geller AC
    Cancer; 2012 Aug; 118(16):4004-13. PubMed ID: 22179775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.